NR2F6 and head and neck squamous cell carcinoma: A research cohort of 383 HNSCC patients revealed that elevated expression of NR2F6 is related to poorer recurrence-free survival, which could be used as a new prognostic indicator for early detection of local recurrences in patients with HNSCC (5).